NCT04108208 2026-04-13A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)Janssen Research & Development, LLCPhase 4 Active not recruiting75 enrolled 9 charts
NCT05348876 2026-03-19A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)BayerPhase 4 Recruiting50 enrolled